JX Luxventure Group Inc.
JXGJX Luxventure Group Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: the price moved −26.0% in a year while annual EPS moved −237.3% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is between stages. Underneath, the last four quarters read mixed. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
JX Luxventure Group Inc. trades at $11.3, between stages. That is +50.7% against its own 200-day average. It sits at 58% of a 52-week range of $3 to $17. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 9 straight weeks.
Today the stock is between stages. At $11.3 it trades +50.7% versus its 200-day average and sits at 58% of its 52-week range ($3–$17).
Against the market, two honest reads. Cumulative: over the last 1.0 years the stock moved −26% while the S&P 500 moved +21% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 9 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
P/E does not price JX Luxventure Group Inc. — earnings are negative, so there is no multiple to rank against its own history. The revenue and margin lines below are where a turn, when it comes, would show first. A P/E returns here the first period the bottom line turns positive.
With earnings negative, P/E does not price — there is no multiple to rank against its own history. The revenue and margin lines below are where the turn, when it comes, will show first.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −237.3% against a −26.0% price move — the price outran earnings, pushing the multiple UP its own range.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
JX Luxventure Group Inc. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 2 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +60.0% | +0.0% | — | — |
| Stock price | −26.0% | — | — | — |
4-Factor Sector Score
49.4/100 — rank 16 of 16 in Apparel Manufacturing · 32% evidence confidence · provisional, ranked below fully-evidenced peers
JX Luxventure Group Inc. scores 49.4 out of 100 against the 16 companies it is compared with in Apparel Manufacturing, ranking 16. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 15.9 + 6.8 + 10.3 + 16.4 = 49.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
JX Luxventure Group Inc. reported $0.1 B of revenue in the Dec 25 quarter, +200.0% year on year. Over 4 years it has compounded at 12.5% a year. The last full year, FY25, came in at $0.1 B. The last four reported quarters add to $0.1 B.
FY25 revenue came in at $0.1 B (+60.0% on the year), capping 4 years at 12.5% compound. The latest quarter (Dec 25) printed $0.1 B, +200.0% year on year.
Pace check: the last four quarters averaged +87.5% growth against the decade's 12.5% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +27.3% over the last 4 quarters against +41.4%/yr over the last 8 — rolling over.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
JX Luxventure Group Inc.'s operating margin is −16.7% in the Dec 25 quarter, −16.7 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −75.0% to 0.0%. The current quarter sits inside that band.
The latest quarter's operating margin is −16.7%, −16.7 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −75.0%–0.0%.
🚨 Why the margin moved: operating margin went −16.7 pp year on year while gross margin went +16.7 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
JX Luxventure Group Inc. posted a net loss of $0.01 B in the Dec 25 quarter. The full FY25 year was a loss of $0.01 B. That loss is 16.7% of the quarter's revenue. The same quarter a year earlier earned $0.0 B. 4 of the last 12 reported quarters were loss-making.
Dec 25 profit was $−0.0 B, null year on year. On the full year, FY25 printed $−0.0 B (null).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
JX Luxventure Group Inc.'s cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $0.0 B of operating cash against $−0.0 B of profit. After null of capital spending, $0.0 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY25: operating cash of $0.0 B against reported profit of $−0.0 B, leaving free cash of $0.0 B after null of capital spending.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
JX Luxventure Group Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
JX Luxventure Group Inc. earns a ROE of −50% in FY25. That is up from a trough of −700% in FY22. Return on invested capital clears the cost of that capital by −40.6 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −12.5% net margin on 2.00× asset turns.
FY25 ROE is −50%, recovered from a FY22 trough of −700% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY25): −12.5% net margin × 2.00× asset turns × 2.00× balance-sheet leverage ≈ −50.0% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: −30.3% − 10.3% = a −40.6 pp spread. The 10.3% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Dividend
JX Luxventure Group Inc. pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
JX Luxventure Group Inc. does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Debt-to-equity is 0.36 at the latest reading — modestly levered; a full borrowings history is not in our numbers.
We hold only the latest reading here: a debt-to-equity of 0.36 — a modest level of leverage behind the returns above. A year-by-year borrowings ladder is not in our numbers for this stock, so we say that rather than draw a chart we cannot support.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
0.1% of JX Luxventure Group Inc.'s tradable float is currently sold short — the crowd is not positioned against this stock. At typical trading volumes those positions would take about 0.6 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 0.1% of the float is sold short, and at typical trading volumes it would take about 0.6 days to buy those positions back. The crowd is not positioned against this stock. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
JX Luxventure Group Inc.: the Z-score reads −1.10. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
🚨 Why it matters: a Z-score of −1.10 is inside the distress zone — the balance sheet is a real risk, not a detail.
The safety line in one sentence: the Z-score reads −1.10.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1G-III Apparel Group, Ltd.GIII | 62.5/100Mixed-positive evidence79% evidence | BREAKING OUT | 16.4/35 Revenue -7.8% · PAT -35.2% · OPM change 14.4 pp 95% evidence | 16.3/25 ROCE 4.1% · OPM 15.9% 76% evidence | 14.7/20 P/E 11× · PEG 0.45 65% evidence | 15.1/20 RS sector 4.7% · RS bench 9.5% · 1Y 49.6%9 of 12 weeks ahead 70% evidence |
| Exact sum: 16.4 + 16.3 + 14.7 + 15.1 = 62.5 · Decision use: Price leads the evidence: RS versus the benchmark is 9.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 2Kontoor Brands, Inc.KTB | 61.4/100Thin evidence · provisional58% evidence | BREAKING OUT | 20.1/35 Revenue — · PAT — · OPM change 2.8 pp 45% evidence | 17.3/25 ROCE 5.4% · OPM 14.7% 76% evidence | 11.1/20 P/E 13.7× · PEG — 15% evidence | 12.9/20 RS sector -2.4% · RS bench 2% · 1Y 23.4%8 of 12 weeks ahead 100% evidence |
| Exact sum: 20.1 + 17.3 + 11.1 + 12.9 = 61.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3Levi Strauss & Co.LEVI | 59.1/100Mixed-positive evidence85% evidence | TURNING | 20.8/35 Revenue 7.3% · PAT 31% · OPM change 0.3 pp 95% evidence | 13.3/25 ROCE 2.6% · OPM 7.8% 76% evidence | 15.1/20 P/E 14.3× · PEG 0.24 65% evidence | 9.9/20 RS sector -3.9% · RS bench 0.5% · 1Y 22.4%7 of 12 weeks ahead 100% evidence |
| Exact sum: 20.8 + 13.3 + 15.1 + 9.9 = 59.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4PVH Corp.PVH | 58.6/100Mixed-positive evidence77% evidence | ASLEEP | 24.1/35 Revenue 3.5% · PAT -60.7% · OPM change 22.8 pp 71% evidence | 10.2/25 ROCE 1.4% · OPM 6.1% 76% evidence | 14.3/20 P/E 29× · PEG 0.18 65% evidence | 10.0/20 RS sector -2.1% · RS bench 2.4% · 1Y 21.8%5 of 12 weeks ahead 100% evidence |
| Exact sum: 24.1 + 10.2 + 14.3 + 10 = 58.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Ralph Lauren CorporationRL | 56.5/100Mixed-positive evidence81% evidence | TURNING | 22.5/35 Revenue 14.6% · PAT 26.8% · OPM change 0.4 pp 83% evidence | 15.4/25 ROCE 3.5% · OPM 9.5% 76% evidence | 11.9/20 P/E 21.7× · PEG 0.72 65% evidence | 6.7/20 RS sector -7.9% · RS bench -3.6% · 1Y 31.1%3 of 12 weeks ahead 100% evidence |
| Exact sum: 22.5 + 15.4 + 11.9 + 6.7 = 56.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Superior Group of Companies, Inc.SGC | 52.3/100Mixed-positive evidence68% evidence | TURNING | 16.1/35 Revenue 1.1% · PAT 28.6% · OPM change 1.2 pp 62% evidence | 7.3/25 ROCE 0.6% · OPM 1.4% 76% evidence | 13.1/20 P/E 17.8× · PEG 0.67 65% evidence | 15.8/20 RS sector 8.6% · RS bench 13.4% · 1Y 24.4%9 of 12 weeks ahead 70% evidence |
| Exact sum: 16.1 + 7.3 + 13.1 + 15.8 = 52.3 · Decision use: Price leads the evidence: RS versus the benchmark is 13.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 7Under Armour, Inc.UAA | 48.5/100Mixed-negative evidence64% evidence | TURNING | 17.1/35 Revenue -3.9% · PAT — · OPM change 3.2 pp 62% evidence | 5.5/25 ROCE -1.1% · OPM -2.9% 76% evidence | 9.1/20 P/E 31× · PEG — 15% evidence | 16.8/20 RS sector 2.7% · RS bench 7.3% · 1Y 25.7%2 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 5.5 + 9.1 + 16.8 = 48.5 · Decision use: Price leads the evidence: RS versus the benchmark is 7.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 8Lakeland Industries, Inc.LAKE | 46.2/100Mixed-negative evidence61% evidence | TURNING | 23.7/35 Revenue 7.8% · PAT — · OPM change 14.7 pp 71% evidence | 7.2/25 ROCE 1.3% · OPM 4.8% 76% evidence | 8.7/20 P/E 90.8× · PEG — 15% evidence | 6.6/20 RS sector -11.8% · RS bench -7.5% · 1Y -14.7%8 of 12 weeks ahead 70% evidence |
| Exact sum: 23.7 + 7.2 + 8.7 + 6.6 = 46.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -11.8% and the one-year return is -14.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 9FIGS, Inc.FIGS | 45.6/100Mixed-negative evidence68% evidence | ASLEEP | 23.1/35 Revenue 18.9% · PAT 100% · OPM change 3 pp 62% evidence | 8.8/25 ROCE 1% · OPM 2.8% 76% evidence | 8.3/20 P/E 67.1× · PEG 1.24 65% evidence | 5.4/20 RS sector -14.8% · RS bench -10.8% · 1Y 74.4%0 of 12 weeks ahead 70% evidence |
| Exact sum: 23.1 + 8.8 + 8.3 + 5.4 = 45.6 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -14.8% and the one-year return is 74.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 10Columbia Sportswear CompanyCOLM | 43.5/100Thin evidence · provisional58% evidence | ASLEEP | 18.1/35 Revenue — · PAT — · OPM change -0.6 pp 45% evidence | 10.8/25 ROCE 1.5% · OPM 5.4% 76% evidence | 10.7/20 P/E 16.1× · PEG — 15% evidence | 3.9/20 RS sector -14.2% · RS bench -10.3% · 1Y 13.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 18.1 + 10.8 + 10.7 + 3.9 = 43.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11Canada Goose Holdings Inc.GOOS | 36.4/100Thin evidence · provisional58% evidence | ASLEEP | 19.3/35 Revenue — · PAT — · OPM change 0 pp 45% evidence | 7.2/25 ROCE -8.4% · OPM 14.3% 76% evidence | 9.5/20 P/E 25× · PEG — 15% evidence | 0.4/20 RS sector -36.4% · RS bench -33.2% · 1Y -21.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19.3 + 7.2 + 9.5 + 0.4 = 36.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Gildan Activewear Inc.GIL | 35.5/100Thin evidence · provisional58% evidence | BASING | 12.1/35 Revenue — · PAT — · OPM change -18.3 pp 45% evidence | 12.4/25 ROCE 3.2% · OPM -0.1% 76% evidence | 8.5/20 P/E 101.6× · PEG — 15% evidence | 2.5/20 RS sector -17.8% · RS bench -13.8% · 1Y 10%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.1 + 12.4 + 8.5 + 2.5 = 35.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Oxford Industries, Inc.OXM | 32.1/100Adverse evidence69% evidence | BASING | 4.9/35 Revenue -2.5% · PAT -148.2% · OPM change -3.5 pp 95% evidence | 10.9/25 ROCE 2.1% · OPM 5.7% 76% evidence | 11.5/20 P/E 10× · PEG — 15% evidence | 4.8/20 RS sector -15.6% · RS bench -11.7% · 1Y -0.3%1 of 12 weeks ahead 70% evidence |
| Exact sum: 4.9 + 10.9 + 11.5 + 4.8 = 32.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14V.F. CorporationVFC | 32.0/100Thin evidence · provisional58% evidence | ASLEEP | 17.0/35 Revenue — · PAT — · OPM change 6.2 pp 45% evidence | 4.7/25 ROCE -1.3% · OPM 2.8% 76% evidence | 9.7/20 P/E 24.9× · PEG — 15% evidence | 0.6/20 RS sector -23.4% · RS bench -19.8% · 1Y 28.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 4.7 + 9.7 + 0.6 = 32 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Ermenegildo Zegna N.V.ZGN | 55.8/100Thin evidence · provisional38% evidence | LEADER | 17.0/35 Revenue — · PAT — · OPM change — 9% evidence | 11.9/25 ROCE 1.9% · OPM — 46% evidence | 9.9/20 P/E 23× · PEG — 15% evidence | 17.0/20 RS sector 16.9% · RS bench 22% · 1Y 91.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 11.9 + 9.9 + 17 = 55.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16JX Luxventure Group Inc.this pageJXG | 49.4/100Thin evidence · provisional32% evidence | 15.9/35 Revenue — · PAT — · OPM change — 9% evidence | 6.8/25 ROCE -27.9% · OPM — 46% evidence | 10.3/20 P/E 19.3× · PEG — 15% evidence | 16.4/20 RS sector 14.4% · RS bench 19.8% · 1Y -26%8 of 8 weeks ahead to 2026-07-10 70% evidence | |
| Exact sum: 15.9 + 6.8 + 10.3 + 16.4 = 49.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is JX Luxventure Group Inc.'s stock price today?
JX Luxventure Group Inc. trades at $11.3, −26.0% over the past year. The company is valued at $0.0 B. The stock sits at 58% of its 52-week range of $3–$17, +50.7% versus its 200-day average. Against the S&P 500 it has been ahead on a trailing-13-week view for 9 weeks. — as of 4 August 2026.
What were JX Luxventure Group Inc.'s latest quarterly results?
JX Luxventure Group Inc. reported revenue of $0.1 B and a net loss of $0.0 B for the Dec 25 quarter. Earnings per share were $−22.66. The operating margin was −16.7%, 16.7 pp lower than a year earlier. — as of 4 August 2026.
What is JX Luxventure Group Inc.'s revenue?
JX Luxventure Group Inc. reported revenue of $0.1 B in the Dec 25 quarter, +200.0% year on year. For the full FY25 fiscal year, revenue was $0.1 B (+60.0%). Over the last 4 years revenue compounded at 12.5% a year. — as of 4 August 2026.
What is JX Luxventure Group Inc.'s profit?
JX Luxventure Group Inc. earned $−0.0 B of net profit in the Dec 25 quarter. Full-year FY25 profit was $−0.0 B. The operating margin ran −16.7% in the latest quarter. — as of 4 August 2026.
What is JX Luxventure Group Inc.'s market cap?
JX Luxventure Group Inc.'s market capitalisation is $0.0 B at a stock price of $11.3. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 4 August 2026.
Does JX Luxventure Group Inc. pay a dividend?
No — JX Luxventure Group Inc. has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 4 August 2026.
How is JX Luxventure Group Inc. performing?
JX Luxventure Group Inc.'s latest readings are below. Against the S&P 500 it has been ahead on a trailing-13-week view for 9 weeks. This describes what the data did, not a rating. — as of 4 August 2026.
Is JX Luxventure Group Inc. beating the market?
On recent form, yes — JX Luxventure Group Inc. has been ahead of the S&P 500 on a trailing-13-week view for 9 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.0 years the stock moved −26% against the S&P 500's +21% — behind the index over the full window. — as of 4 August 2026.
Will JX Luxventure Group Inc.'s stock price go up?
This page publishes no price forecast for JX Luxventure Group Inc. What it measures instead: the stock price is $11.3. Direction is not something this site claims to know. — as of 4 August 2026.
Is the market betting against JX Luxventure Group Inc.?
No — short interest is 0.1% of JX Luxventure Group Inc.'s tradable float, about 0.6 days to cover at typical volumes. That is a low reading: the crowd is not positioned against this stock. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 4 August 2026.
Does JX Luxventure Group Inc. have too much debt?
It is moderate — JX Luxventure Group Inc.'s debt-to-equity is 0.36. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 4 August 2026.
What is JX Luxventure Group Inc.'s capex?
JX Luxventure Group Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY24 alone that was $0.0 B. — as of 4 August 2026.
What is JX Luxventure Group Inc.'s cash flow?
JX Luxventure Group Inc. generated $0.0 B of operating cash flow in FY25 and $0.0 B of free cash flow after null of capital spending. Reported profit that year was $−0.0 B, so operating cash ran ahead of profit. — as of 4 August 2026.
How financially safe is JX Luxventure Group Inc.?
On the balance sheet, the Z-score reads −1.10 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 4 August 2026.
Where is JX Luxventure Group Inc. in its business cycle?
JX Luxventure Group Inc.'s FY25 operating margin was −12.5%, against a 5-year band of −75.0%–0.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran −16.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 4 August 2026.
What could break the JX Luxventure Group Inc. story?
The sharpest disagreement: the price moved −26.0% in a year while annual EPS moved −237.3% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 4 August 2026.
Is JX Luxventure Group Inc. a stock worth studying right now?
This is not investment advice. The machine read: JX Luxventure Group Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 4 August 2026.